🇺🇸 FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7569729

Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507861

Process for the preparation of atomoxetine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488758

Levalbuterol hydrochloride polymorph B

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7482489

Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465831

Levalbuterol hydrochloride Polymorph A

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462743

Polymorphs of memantine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439399

Processes for the preparation of atomoxetine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439398

Enantiomerically pure atomoxetine and tomoxetine mandelate

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378553

Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355078

Processes for the preparation of tomoxetine

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7317127

Process for the optical resolution and recycling of tomoxetine

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted